Hepatitis B, Chronic

Explore clinical trials studying Hepatitis B, Chronic. Study availability and eligibility vary by location and protocol.

532 public trials 70 recruiting studies

Refine in advanced search Browse all conditions

Hepatitis B, Chronic trial results

Completed

NCT01320943

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +26 more
Locations: Leberzentrum am Checkpoint Berlin, Germany

Charite CVK Berlin, Germany

Zentrum für HIV und Hepatitis Düsseldorf, Germany

J.W. Goethe Universitaetsklinikum Frankfurt, Germany

View all 13 locations

Completed

NCT01353742

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: GSK Investigational Site Shatin, New Territories, Hong Kong

Completed

NCT01730508

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: The Fifth Hospital of Shijiazhuang Baoding, China

Beijing Ditan Hospital Beijing, China

Beijing 302 Hospital; No. 2 Infectious Disease Section Beijing, China

Beijing Friendship Hospital Beijing, China

View all 88 locations

Completed

NCT02387463

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: Beijing Ditan hospital,Capital Medical University Beijing, Beijing Municipality, China

Completed

NCT00120354

Conditions: Blood-Borne Infections, Chemically-Induced Disorders, Chronic Disease, +18 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

Completed

NCT00537537

Conditions: Blood-Borne Infections, Bronchial Diseases, Bronchiolitis, +25 more
Locations: Novartis Investigative Site Hyderabad, India

Novartis Investigative Site Mumbai, India

Novartis Investigative Site Vellore, India

Completed

NCT00467545

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: Novartis Investigative Site (705-035) Daegu, South Korea

Novartis Investigative Site , (420-717) Gyeonggi-do, South Korea

Novartis Investigative Site , (405-760) Incheon, South Korea

Novartis Investigative Site , (136-705) Seoul, South Korea